Synteract, Inc. (San Diego) and Mpex Pharmaceuticals, Inc. Team Up for Cystic Fibrosis Walk and Cure

SAN DIEGO--(BUSINESS WIRE)--Synteract, Inc., a full-service, global contract research organization (CRO), and Mpex Pharmaceuticals, a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, have partnered for the second annual Great Strides fundraiser to benefit cystic fibrosis (CF). The two companies are also working together on two phase 3 trials to combat the diseas